SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-010136
Filing Date
2024-04-03
Accepted
2024-04-03 18:00:15
Documents
1
Period of Report
2024-04-01

Document Format Files

Seq Description Document Type Size
1 form4-04032024_060404.html 4  
1 form4-04032024_060404.xml 4 7718
  Complete submission text file 0001415889-24-010136.txt   9196
Mailing Address C/O TARGANTA THERAPEUTICS CORPORATION 222 THIRD STREET SUITE 2300 CAMBRIDGE MA 02142
Business Address
Eldridge George A (Reporting) CIK: 0001413006 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40544 | Film No.: 24820529

Mailing Address 930 WINTER STREET SUITE M-500 WALTHAM MA 02451
Business Address 930 WINTER STREET SUITE M-500 WALTHAM MA 02451 617-443-2400
Aerovate Therapeutics, Inc. (Issuer) CIK: 0001798749 (see all company filings)

IRS No.: 831377888 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)